Transformational Solution Streamlines Entertainment Media Finance Processes

AMSTERDAM, Netherlands, Sept. 17, 2024 /PRNewswire-PRWeb/ — Whip Media, the leading SaaS platform empowering data-driven decisions across the content ecosystem, and Hooper Media, a pioneer in processing software for participations, residuals, and royalties, announced a strategic partnership today at IBC 2024. This innovative collaboration is set to transform entertainment media finance by addressing critical inefficiencies within finance teams across the industry.

The entertainment industry faces significant challenges managing participations and residuals due to manual data processing and complex calculations. Finance teams often spend excessive time sourcing and manipulating revenue data in Excel, leading to time-consuming and error-prone processes. The partnership between Whip Media and Hooper Media is designed to systematize and automate these workflows, significantly improving efficiency, accuracy, and productivity.

“We are thrilled to partner with Hooper Media to provide an end-to-end solution for participations and residuals processing. This collaboration enables us to address the critical pain points of finance teams, offering a streamlined and automated approach to media finance,” said Mike Sid, Chief Strategy Officer at Whip Media.

The Whip Media and Hooper Media partnership offers a powerful combination of solutions:

Streamlined Data Handling: Whip Media’s solution ingests, aggregates, and normalizes third-party data, seamlessly feeding it into Hooper Media’s system for further processing.Automated Calculations: Hooper Media’s Calculation Engine automates the consolidation of revenue and expense sources for participations and residuals reporting, including ACTRA & Equity residuals, reducing manual effort and enhancing accuracy.

By leveraging best practices and extensive industry experience, this partnership delivers a modern, flexible solution that simplifies complex financial processes, empowering media companies to manage their operations with greater precision and efficiency.

“By combining our innovative calculation engine with Whip Media’s powerful data management capabilities, we offer a truly transformational solution for the entertainment industry. Together, we are making it easier for finance teams to handle the complexities of participations and residuals,” said Steve Pitts, CEO at Hooper Media.

About Whip Media

Whip Media empowers data-driven decisions across the entire entertainment ecosystem. Our software provides the industry’s most robust insights, enabling leading media organizations to make smarter, more profitable content decisions faster. We help our clients scale and optimize their streaming strategies through automation, visibility, and intelligence. For more information, visit www.whipmedia.com.

About Hooper Media

Hooper Media is a software development company specializing in solutions for processing residuals, participations, royalties, and media finance. Backed by a team with decades of experience and industry best practices, our modern and flexible Calculation Engine simplifies complex processing, improves accuracy, and reduces effort, empowering media companies to manage their financial operations with greater efficiency and precision. For more information, visit www.hooper-media.com.

For additional information, please contact:

Jerry Inman

press@whipmedia.com

Media Contact

Jerry Inmann, Whip Media, 1 2126732222, jinman@whipmedia.com, www.whipmedia.com

View original content to download multimedia:https://www.prweb.com/releases/whip-media-and-hooper-media-announce-partnership-to-automate-participations-and-residuals-302250567.html

SOURCE Whip Media

RALEIGH, N.C., Sept. 17, 2024 /PRNewswire/ – Librestream, a provider of innovative knowledge and collaboration solutions, is pleased to announce a partnership with ManTech, a leading provider of technology solutions for mission-critical national security programs. ManTech will implement Librestream’s Onsight software to more efficiently support the maintenance of ground vehicles, improve mission readiness, and reduce the need of forward deployed maintainer personnel for the U.S. Army.

This collaboration marks a significant milestone in Librestream’s commitment to delivering cutting-edge technology enhancing operational efficiency, effectiveness and safety in the defense sector. Onsight is designed to streamline knowledge retrieval, standardize knowledge preservation, and enable enhanced collaboration with AI & AR capabilities. By leveraging these technologies, ManTech aims to improve maintenance processes, reduce downtime, and ensure the highest levels of readiness for the U.S. Army’s ground vehicle fleet.

“We are thrilled to partner with ManTech in this critical initiative,” said John Bishop, CEO of Librestream. “Onsight is ideally suited for the rigorous demands of military maintenance operations, providing real-time access to expert knowledge and support. This partnership underscores our dedication to supporting the U.S. Army’s mission and enhancing the performance and reliability of its ground vehicles.”

ManTech has a long-standing reputation for delivering exceptional technology solutions to the defense and intelligence communities. By integrating Onsight into their maintenance operations, they will be able to offer unparalleled support to the U.S. Army, ensuring that ground vehicles are maintained to the highest standards with greater mission readiness.

The deployment of Onsight will involve comprehensive training for maintenance personnel, ensuring they can fully utilize the software’s capabilities. This initiative is expected to set a new standard for ground vehicle maintenance in the defense sector, contributing to improved operational readiness and mission success.

About Librestream

Librestream is a leading provider of software solutions that enhance operational efficiency and effectiveness. Our flagship product, Onsight, offers advanced capabilities in knowledge retrieval, data preservation, and enhanced collaboration with AI & AR capabilities. We are committed to meeting the evolving needs of our clients across various sectors, including defense, manufacturing, aerospace, and energy. www.librestream.com.

About ManTech

ManTech provides innovative technology solutions for mission-critical national security programs. With a focus on delivering exceptional results, ManTech supports the defense, intelligence, and federal civilian sectors through advanced technology solutions and services. For more information, visit www.mantech.com.

View original content:https://www.prnewswire.com/news-releases/librestream-partners-with-mantech-to-enhance-ground-vehicle-maintenance-for-the-us-army-302250632.html

SOURCE LibreStream Technologies, Inc.

Patient survey currently underway in partnership with the HealthTree Foundation; data expected in Q1 2025

TEL AVIV, Israel and WALTHAM, Mass., Sept. 17, 2024 /PRNewswire/ — BioLineRx Ltd. (NASDAQ: BLRX) (TASE: BLRX), a commercial stage biopharmaceutical company pursuing life-changing therapies in oncology and rare diseases, today announced the launch of Mobilization Matters, a digital resource for people with multiple myeloma who are preparing for stem cell collection for an autologous stem cell transplant. Launched on Apheresis Awareness Day, this platform offers patient stories, educational resources, and more to support those undergoing this critical phase of treatment.

In conjunction with this launch, BioLineRx is partnering with the HealthTree Foundation to conduct the Mobilization Matters Stem Cell Collection Survey. This initiative aims to gather insights from patients about their experiences with stem cell collection and apheresis as part of their multiple myeloma journey. The findings will help illuminate patient experiences, enhance understanding, and improve care and support strategies. Survey results are expected in Q1 2025.

“We are deeply committed to supporting multiple myeloma patients and their care partner through their stem cell collection process,” said Holly May, MBA, President of BioLineRx USA. “Our goal is to enrich education and foster dialogue, empowering patients with knowledge. Mobilization Matters is designed to achieve this by amplifying patient voices and providing comprehensive resources.”

In addition to patient stories and survey information, Mobilization Matters features a discussion guide to facilitate conversations between patients and their healthcare teams before apheresis. For more information, visit www.mobilizationmatters.com.

About the Mobilization Matters Survey

The Mobilization Matters Stem Cell Collection Survey is being conducted by the HealthTree Foundation on behalf of BioLineRx among adults with multiple myeloma (ages 18+) who have attempted stem cell collection for a planned transplant. Developed in collaboration with experts from leading institutions and patient advisors, the survey aims to provide valuable insights into the emotional, physical, and daily life challenges patients face during the stem cell collection process. Results will be shared on mobilizationmatters.com, once available.

“This survey will provide important insights into the patient experience with stem cell collection, offering a deeper understanding of the potential challenges involved,” said Beth B. Giblin, PharmD, Head of US Medical Affairs, BioLineRx. “Our aim is to use the findings to build on the existing literature and inform data-driven approaches to patient care and support.”

“We need to better understand the patient’s journey during the stem cell collection process,” said Jenny Ahlstrom, Founder & CEO of the HealthTree Foundation. “We are excited to use these data to advance education and drive patient-centered care. This collaboration supports our mission to empower multiple myeloma patients with knowledge, enhance their care experiences, and contribute meaningfully to research.”

This survey marks the first patient experience study by the HealthTree Foundation on this critical topic. The research is being conducted through the HealthTree Cure Hub, a patient-data platform and community with over 14,000 registered myeloma patients, where participants can opt into surveys and studies to accelerate research and shape the future of healthcare.

About Stem Cell Mobilization for Multiple Myeloma

Autologous stem cell transplantation (ASCT) is the preferred first-line treatment for multiple myeloma – the second most common blood cancer – and is integral to the prospect of improving survival and helping to restore the immune system.i,ii

Prior to ASCT, patients undergo apheresis, a procedure to collect stem cells for transplant. Stem cells are made deep in the bone marrow and need to be mobilized from the bone marrow to the bloodstream for collection during apheresis.iii,iv

ASCT success depends on adequate mobilization and collection of stem cells.iii While more multiple myeloma patients are candidates for ASCT than ever before, stem cell mobilization and collection is a growing challenge. This is due to factors such as increasing proportion of older patients receiving ASCTvi and the use of standard 3- and 4-drug induction therapy, which can further impair mobilization with fewer cells mobilized and additional days of apheresis required.vii, viii

About the HealthTree Foundation

HealthTree is a global nonprofit using innovation to save lives. They provide lifetime personalized support and education, meaningful patient-to-patient connections and a powerful patient data portal. HealthTree’s cutting-edge technology empowers patients to better manage their health and engages them as critical contributors to lifesaving research. The trust of their patient community allows HealthTree to provide continually updated, real-world patient data to researchers who seek to advance clinical care and find cures for blood cancers. Visit healthtree.org today. 

About BioLineRx

BioLineRx Ltd. (NASDAQ: BLRX) (TASE: BLRX) is a commercial stage biopharmaceutical company pursuing life-changing therapies in oncology and rare diseases. Since receiving approval for our first marketed product in the U.S., BioLineRx is continuing to advance a pipeline of investigational drugs for patients with sickle cell disease, pancreatic cancer, and other solid tumors. Headquartered in Israel, and with operations in the U.S., the company is driving innovative therapeutics with end-to-end expertise in development and commercialization, ensuring life-changing discoveries move beyond the bench to the bedside.

Learn more about who we are, what we do, and how we do it at www.biolinerx.com, or on Twitter and LinkedIn.

Logo: https://mma.prnewswire.com/media/2154863/4858892/BioLineRx_Ltd_Logo.jpg

i Dhakal B, et al. Transplant Cell Ther. 2022;28(6):284-293.
ii Kumar SK, et al. Blood. 2008;111(5):2516-2520.
iii Giralt S, Costa L, Schriber J, et al. Biol Blood Marrow Transplant. 2014;20(3):295-308.
iv American Cancer Society. Types of Stem Cell and Bone Marrow Transplants.
v Swan D, Hayden PJ, Eikema D-J, et al. BR J Haematol. 2022;197(1):82-96.
vi Morris CL, Siegel E, Barlogie B, et al. Br J Haematol. 2003;120(3):413-423.
vii Hulin C, Offner F, Moreau P, et al. Haematologica. 2021;106(8):2257-2260.
viii Chhabra S, Callander N, Watts NL, et al. Transplant Cell Ther. 2023;29(3):174.e1-174.e10.

CONTACTS:
United States
John Lacey
BioLineRx
IR@biolinerx.com

View original content:https://www.prnewswire.com/news-releases/biolinerx-launches-mobilization-matters-a-digital-resource-for-people-with-multiple-myeloma-preparing-for-stem-cell-collection-302250690.html

SOURCE BioLineRx Ltd.